Hook & thesis
Palantir just delivered another monster quarter and the market's price action gives a clear trading window. The company reported revenue growth north of 90% and raised full-year guidance, forcing a reassessment of risk after the big correction earlier this summer. I am upgrading my stance to constructive and recommending a tactical long: enter at $172.08, protect with a stop at $156.00, and target $220.00 over the next 180 trading days.
This is a trade, not a valuation endorsement at any price. You are buying a high-growth, high-margin software company that is still richly priced. The move is a structured bet that near-term execution and continued commercial adoption of Palantir's AIP platform will keep results above the market's stretched expectations.
The business and why the market should care
Palantir builds enterprise and government software platforms used for large-scale analytics and operational decision-making. The product set is squarely aimed at an AI-driven market: data integration, model orchestration, and mission-critical analytics for defense, healthcare, energy and financial services. That mix matters because the company is transitioning from being defense-heavy to a far more balanced commercial profile, which expands addressable markets and typically commands higher multiple expansion in software peers.
Why this matters now: management's latest results show the commercial shift is real and accelerating. On 08/11/2026 Palantir reported Q2 revenue growth of 93% year-over-year and said U.S. commercial revenue jumped 149% y/y. Management raised full-year guidance to $8.154 billion, a sign they are confident the enterprise momentum is sustainable. High net margins (reported near 55% in coverage) and strong free cash flow ($3.358 billion) combine growth with profitability - the rare Rule-of-40 type profile that commands premium multiples.
Support from the numbers
| Metric | Value |
|---|---|
| Current price | $172.08 |
| Market cap | $413.5B |
| P/E | ~137x |
| Price/Sales | 67.36x |
| Free cash flow | $3.358B |
| Return on equity | 30.86% |
| 52-week range | $106.37 - $207.52 |
| 30-day avg volume | ~45.9M |
Those figures show the central tension: Palantir is delivering rare growth and cash generation, but the valuation assumes continued near-perfect execution. The market cap of roughly $413.5B and an EV/EBITDA north of 150x reflect that premium. That said, if the company can keep scaling commercial revenue (U.S. commercial +149% y/y) and translate platform deployments into sticky recurring ARR, premium multiples can be earned — and that’s the bet this trade makes.
Valuation framing
At $172.08 the stock trades at roughly 137x trailing earnings and a price-to-sales multiple in the high double-digits (P/S ~67x). Those multiples are not sustainable for a mature software company, but Palantir isn't mature in the commercial sense: the rapid enterprise adoption of AIP is re-rating the business model. Compare that to standard SaaS norms and the gap is obvious - Palantir is priced for perfection.
My approach: treat valuation as a guardrail, not a blocker. The long trade recognizes the probability that the next several quarters will show continued strong top-line prints and margin upside that keeps investors willing to pay a high multiple. If growth slows or margins compress, the valuation will be the first thing to correct — hence the strict stop at $156.00.
Catalysts (what will push the stock higher)
- Continued beat-and-raise cadence from the next couple of quarters driven by commercial AIP deployments.
- Large enterprise customer wins and multi-year contracts that expand ARR visibility.
- Upgrades from high-profile analysts and banks, which widen the buyer base — Citi and others have already lifted targets following Q2.
- Positive macro or defense spending news that reinforces government revenue stability while commercial accelerates.
Trade plan (entry, stop, target and horizon)
Trade direction: Long
Entry price: $172.08 (current price) — size the position with no more than a standard allocation given the high valuation and volatility.
Stop loss: $156.00 — technical cut below short-term support and below the 10-day SMA buffer; preserves capital if momentum rolls over.
Target: $220.00 — consistent with near-term bull-case scenarios and existing market commentary predicting $220+ by year-end.
Horizon: long term (180 trading days). I expect this trade to play out over multiple quarters as commercial revenue growth and margin expansion translate into measurable earnings upside. 180 trading days gives enough runway for the market to re-price the company if Palantir continues to beat.
Execution notes
- Use limit orders to enter near $172.08 to avoid short-term slippage. Consider scaling in if you are adding to size — a two-leg entry with a second tranche below $165 can reduce average cost.
- Re-evaluate position at quarterly prints. If revenue guidance is raised again and margin outlook improves, move stop to breakeven and trim partial gains on the way to $220.
Risks and counterarguments
Every trade here balances a clear upside with meaningful downside risks. I list the principal concerns below along with at least one counterargument to my bullish stance.
- Valuation risk: At ~137x earnings and P/S >60x, Palantir is priced for a near-perfect growth trajectory. Any small miss can cause a fast re-rate downward.
- Execution risk: Converting large enterprise pilots into sticky ARR is hard. If churn or implementation issues appear, the premium evaporates.
- Concentration and customer risk: While commercial growth is accelerating, government contracts still matter. Policy, budget shifts or program delays could hit revenue.
- Sentiment and liquidity risk: High short-volume days and episodic retail flows mean the stock can gap hard — both up and down. Large block sales (e.g., big holders trimming) can pressure price.
- Macro/market risk: In a risk-off environment, high multiple names are punished first; Palantir’s premium makes it vulnerable during market drawdowns.
Counterargument: The bull case is already reflected in the multiples, and paying up now leaves little margin of error. You could wait for a retracement toward the 50-day EMA (~$144.46) or a pullback to lower volatility before buying. This is reasonable for risk-averse investors — the stock can easily give up 20-30% if macro sentiment deteriorates.
What would change my mind
I will abandon the upgrade and close the position if any of the following happens: a) the next quarter shows sequential slowing in U.S. commercial growth or contraction in core customer ARR, b) management pulls guidance or issues conservative commentary on sales cycles, c) net margins drop materially indicating margin pressure, or d) macro-driven risk aversion pushes the stock below $156 on high volume and the company shows no sign of commercial traction thereafter.
Conclusion
Palantir just completed the correction I called earlier this year: the company corrected, digested, and now the fundamentals have ratcheted higher. Q2 results — 93% top-line growth and U.S. commercial up 149% — plus raised guidance, make a tactical long defensible. That said, this is not a low-risk trade. The valuation requires near-flawless execution. The recommended plan is to buy at $172.08, protect with a $156 stop, and target $220 over a 180 trading-day window. Keep position size disciplined and re-evaluate aggressively on the next prints.